A. M. Carter

P2X4 purinergic receptors offer a therapeutic target for aggressive prostate cancer

J. Hicks, A. D. De Marzo, C. Joshu, 2021, The Journal of pathology.

P2X4 Purinergic Receptors as a Therapeutic Target in Aggressive Prostate Cancer

J. Hicks, A. D. De Marzo, C. Joshu, 2021, bioRxiv.

Complete deletion of Apc results in severe polyposis in mice

T. Jacks, R. Bronson, D. Crowley, 2009, Oncogene.